Cargando…
Future prospects for CD8(+) regulatory T cells in immune tolerance
CD8(+) Tregs have been long described and significant progresses have been made about their phenotype, their functional mechanisms, and their suppressive ability compared to conventional CD4(+) Tregs. They are now at the dawn of their clinical use. In this review, we will summarize their phenotypic...
Autores principales: | Flippe, Léa, Bézie, Séverine, Anegon, Ignacio, Guillonneau, Carole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027528/ https://www.ncbi.nlm.nih.gov/pubmed/31593314 http://dx.doi.org/10.1111/imr.12812 |
Ejemplares similares
-
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8(+) Regulatory T Cells
por: Benallegue, Nail, et al.
Publicado: (2022) -
Genetic engineering of human and mouse CD4(+) and CD8(+) Tregs using lentiviral vectors encoding chimeric antigen receptors
por: Vimond, Nadège, et al.
Publicado: (2020) -
Alloantigenic recognition properties of CD8(+) regulatory T cells
por: Picarda, Elodie, et al.
Publicado: (2011) -
Generation of CD34(+)CD43(+) Hematopoietic Progenitors to Induce Thymocytes from Human Pluripotent Stem Cells
por: Flippe, Léa, et al.
Publicado: (2022) -
IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection
por: Bézie, Séverine, et al.
Publicado: (2020)